These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2202187)

  • 21. Thyroid-stimulating antibodies in patients with autoimmune disorders.
    Strakosch CR; Joyner D; Wall JR
    J Clin Endocrinol Metab; 1978 Aug; 47(2):361-5. PubMed ID: 263731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antibodies against thyroid gland peroxidase and thyroglobulin in various thyroid diseases].
    Földes I; Lévay A
    Orv Hetil; 1994 Jul; 135(29):1579-84. PubMed ID: 8058301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease.
    Goh SY; Ho SC; Seah LL; Fong KS; Khoo DH
    Clin Endocrinol (Oxf); 2004 May; 60(5):600-7. PubMed ID: 15104563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The transformation of Basedow's struma into nodular goiter: a reason for recurrence of hyperthyroidism].
    Studer H; Huber G; Derwahl M; Frey P
    Schweiz Med Wochenschr; 1989 Feb; 119(7):203-8. PubMed ID: 2652283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A study of biological and histological criteria of thyroid autoimmunity in diffuse goiters with hyperthyroidism].
    Leprat F; Felicie-Dellan E; Trouette H; Latapie MJ; Masson B; De Mascarel A; Latapie JL; Roger P
    Ann Endocrinol (Paris); 1997; 58(5):393-8. PubMed ID: 9685997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticomplementary activity in diffuse and nodular goiters.
    Feldt-Rasmussen U; Bech K; Date J; Thyme S; Hannover Larsen J; Nielsen H
    Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):365-70. PubMed ID: 583537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevalence of thyroid-stimulating antibodies in goitrous disease assessed by cytochemical section bioassay.
    Smyth PP; Neylan D; O'Donovan DK
    J Clin Endocrinol Metab; 1982 Feb; 54(2):357-61. PubMed ID: 6119323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Similarity and dissimilarity between clinical and laboratory findings, especially anti-thyrotropin receptor antibody in ophthalmic Graves' disease without persistent hyperthyroidism and hyperthyroid Graves' disease.
    Kosugi S; Inoue D; Sugawa H; Enomoto T; Mori T; Imura H
    Endocrinol Jpn; 1990 Jun; 37(3):343-54. PubMed ID: 2253584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmune thyroid disease.
    Bottazzo GF; Doniach D
    Annu Rev Med; 1986; 37():353-9. PubMed ID: 2871804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anti-thyroglobulin and anti-thyroid microsomal antibodies in thyroid disorders].
    Lee LS
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 Aug; 15(3):202-11. PubMed ID: 6897219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid stimulating antibodies, thyroglobulin antibodies and serum proteins during treatment of Graves' disease with radioiodine or propylthiouracil.
    Feldt-Rasmussen U; Bech K; Date J; Hyltoft Pedersen P; Johansen K; Nistrup Madsen S
    Allergy; 1982 Apr; 37(3):161-7. PubMed ID: 6127965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid growth-stimulating immunoglobulins in goitrous disease: relationship to thyroid-stimulating immunoglobulins.
    Smyth PP; McMullan NM; Grubeck-Loebenstein B; O'Donovan DK
    Acta Endocrinol (Copenh); 1986 Mar; 111(3):321-30. PubMed ID: 2870597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperthyroidism due to Graves' disease and due to autonomous goiter.
    Schicha H; Emrich D; Schreivogel I
    J Endocrinol Invest; 1985 Oct; 8(5):399-407. PubMed ID: 3841136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy.
    Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM
    Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relapses of hyperthyroidism in patients treated with radioiodine for nodular toxic goiter: relation to thyroid autoimmunity.
    Custro N; Ganci A; Scafidi V
    J Endocrinol Invest; 2003 Feb; 26(2):106-10. PubMed ID: 12739735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathogenesis of hyperthyroidism].
    Höfer R; Aiginger P; Weissel M
    Acta Med Austriaca; 1978; 5(3):68-70. PubMed ID: 377885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered immunoreactivity of thyroglobulin in thyroid disease.
    Kim PS; Dunn AD; Dunn JT
    J Clin Endocrinol Metab; 1988 Jul; 67(1):161-8. PubMed ID: 3379131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxic multinodular goiter: a variant of autoimmune hyperthyroidism.
    Kraiem Z; Glaser B; Yigla M; Pauker J; Sadeh O; Sheinfeld M
    J Clin Endocrinol Metab; 1987 Oct; 65(4):659-64. PubMed ID: 2888784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recent findings on the etiopathogenesis of multinodular goiter. I. Immunoglobulin stimulation of thyroid growth].
    Sussi PL; Francia G; Azzolina LG; Daví MV; Musumeci C; Zamboni G
    Chir Ital; 1991; 43(3-4):77-83. PubMed ID: 1685944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre.
    Chiovato L; Santini F; Vitti P; Bendinelli G; Pinchera A
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):803-6. PubMed ID: 8033373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.